155 related articles for article (PubMed ID: 21159661)
1. B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin.
Cao Y; Zhang L; Kamimura Y; Ritprajak P; Hashiguchi M; Hirose S; Azuma M
Cancer Res; 2011 Feb; 71(4):1235-43. PubMed ID: 21159661
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory molecule B7-H1 (CD274) contributes to skin carcinogenesis.
Cao Y; Zhang L; Ritprajak P; Tsushima F; Youngnak-Piboonratanakit P; Kamimura Y; Hashiguchi M; Azuma M
Cancer Res; 2011 Jul; 71(14):4737-41. PubMed ID: 21730022
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
[TBL] [Abstract][Full Text] [Related]
4. Triptolide inhibits B7-H1 expression on proinflammatory factor activated renal tubular epithelial cells by decreasing NF-kappaB transcription.
Chen Y; Zhang J; Li J; Zhao T; Zou L; Tang Y; Zhang X; Wu Y
Mol Immunol; 2006 Mar; 43(8):1088-98. PubMed ID: 16129490
[TBL] [Abstract][Full Text] [Related]
5. B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma.
Strome SE; Dong H; Tamura H; Voss SG; Flies DB; Tamada K; Salomao D; Cheville J; Hirano F; Lin W; Kasperbauer JL; Ballman KV; Chen L
Cancer Res; 2003 Oct; 63(19):6501-5. PubMed ID: 14559843
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274).
Lee SJ; Jang BC; Lee SW; Yang YI; Suh SI; Park YM; Oh S; Shin JG; Yao S; Chen L; Choi IH
FEBS Lett; 2006 Feb; 580(3):755-62. PubMed ID: 16413538
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas.
Williams IR; Ort RJ; Daley D; Manning L; Karaoli T; Barnhill RL; Kupper TS
J Immunol; 1996 May; 156(9):3382-8. PubMed ID: 8617964
[TBL] [Abstract][Full Text] [Related]
8. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.
Liu Y; Zeng B; Zhang Z; Zhang Y; Yang R
Clin Immunol; 2008 Dec; 129(3):471-81. PubMed ID: 18790673
[TBL] [Abstract][Full Text] [Related]
9. Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma.
Tsushima F; Tanaka K; Otsuki N; Youngnak P; Iwai H; Omura K; Azuma M
Oral Oncol; 2006 Mar; 42(3):268-74. PubMed ID: 16271509
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
11. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
12. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses.
Tsushima F; Iwai H; Otsuki N; Abe M; Hirose S; Yamazaki T; Akiba H; Yagita H; Takahashi Y; Omura K; Okumura K; Azuma M
Eur J Immunol; 2003 Oct; 33(10):2773-82. PubMed ID: 14515261
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
[TBL] [Abstract][Full Text] [Related]
14. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
15. Co-inhibitory role of T-cell-associated B7-H1 and B7-DC in the T-cell immune response.
Seo SK; Seo HM; Jeong HY; Choi IW; Park YM; Yagita H; Chen L; Choi IH
Immunol Lett; 2006 Feb; 102(2):222-8. PubMed ID: 16236366
[TBL] [Abstract][Full Text] [Related]
16. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis.
Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J
Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
Waeckerle-Men Y; Starke A; Wüthrich RP
Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells.
Lee SK; Seo SH; Kim BS; Kim CD; Lee JH; Kang JS; Maeng PJ; Lim JS
J Dermatol Sci; 2005 Nov; 40(2):95-103. PubMed ID: 16085391
[TBL] [Abstract][Full Text] [Related]
19. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role.
Youngnak-Piboonratanakit P; Tsushima F; Otsuki N; Igarashi H; Machida U; Iwai H; Takahashi Y; Omura K; Yokozeki H; Azuma M
Immunol Lett; 2004 Jul; 94(3):215-22. PubMed ID: 15275969
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve.
Uçeyler N; Göbel K; Meuth SG; Ortler S; Stoll G; Sommer C; Wiendl H; Kleinschnitz C
Exp Neurol; 2010 Mar; 222(1):153-60. PubMed ID: 20051242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
